Mother's Voice Therapy for Premature Birth
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of Mother's Voice Therapy for Premature Birth?
Is Mother's Voice Therapy safe for premature infants?
How does Mother's Voice Therapy differ from other treatments for premature infants?
Mother's Voice Therapy is unique because it involves using the mother's voice, either live or recorded, to help stabilize preterm infants by reducing cardiorespiratory events and potentially improving feeding and growth. Unlike other treatments, it also benefits mothers by increasing oxytocin levels, which can reduce anxiety and enhance their caregiving abilities.12389
What is the purpose of this trial?
The purpose of this study is to examine whether playing recordings of a mother's voice to her infant while in the hospital nursery is an effective treatment for promoting healthy brain and language development in infants born preterm.
Research Team
Katherine E Travis, PhD
Principal Investigator
Stanford University
Eligibility Criteria
This trial is for premature infants born at Stanford Children's Hospital between 24 and nearly 32 weeks of gestation. It excludes those with congenital anomalies, seizure disorders, severe brain injuries like grade III-IV hemorrhages or cystic PVL, major hearing loss, or conditions requiring transfer before reaching 36 weeks post-menstrual age.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Infants are played recordings of their mother's voice 2-3 hours daily in the intermediate care nursery until discharge
Follow-up
Participants are monitored for long-term impacts on brain and language development, including MRI scans and language assessments
Treatment Details
Interventions
- Control Treatment
- Language Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator